Internal Medicine Doctors in Socorro, NM Accepting Medicare

3 Internal Medicine doctors found. Showing 1 - 3

Adrian Renaldi, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1300 Enterprise Rd, Socorro, NM 87801 Phone: 575-835-4444

Beth Kirkhart, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Neel Ave, Socorro, NM 87801 Phone: 505-835-2940    Fax: 505-835-2216

Dr. Sandra Elizabeth Allen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 Enterprise Rd, Socorro, NM 87801 Phone: 575-835-4444    Fax: 575-835-1010

News Archive

Novel potassium channel genes could be promising therapeutic targets for alcohol use disorder

A handful of FDA-approved drugs exist for treating individuals with alcohol use disorder but they have been largely ineffective at reducing the high rates of relapse. As such, there remains a critical need to identify and develop alternative pharmacological treatment options.

IU researchers receive $1.5 million NIH grant to advance study on diabetes risks

A $1.5 million grant from the National Institutes of Health will advance work by Indiana University researchers that seeks to identify Americans at risk for diabetes and other metabolic disorders based on their exposure to trace minerals in the environment.

New York University and Health Data Management launch new healthcare software testing facility

The Polytechnic Institute of New York University and Health Data Management, the premier print and online publication for healthcare IT executives, today announced the launch of a new healthcare software testing facility.

What is the frequency of COVID testing to prevent Delta variant transmission?

In a new study published on the medRxiv* preprint server, scientists have used available data on the Delta variant's viral load to infer its infectiousness and, subsequently, estimate the reduction in its transmission brought about by surveillance testing. The testing, done at different frequencies, was performed on a susceptible population. The cases of both the original Wuhan strain and the Delta variant were considered.

Key molecule can be used to assess prognosis of triple negative breast cancer

Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

Read more Medical News

› Verified 4 days ago